Session XII: Treatment in Relapsed/ Refractory MM

Moderator(s)

• 

  Ruben Niesvizky, MD

  Weill Cornell Medicine/NewYork-Presbyterian Hospital
  New York, New York, United States

Presenter(s)

• 

  James Berenson, MD

  Institute for Myeloma and Bone Cancer Research
  West Hollywood, California, United States
• 

  Faith Davies, MD

  Perlmutter Cancer Center, NYU Grossman School of Medicine
  New York, New York, United States
• 

  Mateo Mejia Saldarriaga, MD

  Weill Cornell Medicine
  New York, New York, United States
• 

  Joseph Mikhael, MD, MEd, FRCPC, FACP

  Applied Cancer Research and Drug Discovery
  Translational Genomics Research Institute (TGen), City of Hope Cancer Center
  Phoenix, Arizona, United States
• 

  Adriana Rossi, MD

  Center of Excellence for Multiple Myeloma
  Mount Sinai School of Medicine
  New York, New York, United States

Talks in this session are supported by an educational grant from Karyopharm Therapeutics.

Presentations:

• 4:00 PM – 4:05 PM ET

  Pre-Session Audience Survey
• 4:05 PM – 4:25 PM ET

  The Early Relapsing Patient. When to Rechallenge or Change Class?
  

  Speaker: Faith E. Davies, MD – Perlmutter Cancer Center, NYU Grossman School of Medicine
• 4:25 PM – 4:40 PM ET

  Debate: MRD Analysis - MRD is Necessary Determinant on Outcomes Both in Clinical Practice and Clinical Research
  

  Debate Speaker: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
• 4:40 PM – 4:55 PM ET

  Debate: MRD Analysis - MRD Does Not Reflect the Biology and Clinical Complexities of the Disease
  

  Debate Speaker: James R. Berenson, MD – Institute for Myeloma and Bone Cancer Research
• 4:55 PM – 5:15 PM ET

  The Multiple Refractory Patient: From CelMods to XPO1 Inhibitors
  

  Speaker: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
• 5:15 PM – 5:35 PM ET

  Panel Discussion and Q&A
  

  Panelist: James R. Berenson, MD – Institute for Myeloma and Bone Cancer Research

  Panelist: Faith E. Davies, MD – Perlmutter Cancer Center, NYU Grossman School of Medicine

  Panelist: Joseph Mikhael, MD, MEd, FRCPC, FACP – Translational Genomics Research Institute (TGen), City of Hope Cancer Center
• 5:35 PM – 6:00 PM ET

  Case Discussions
  

  Moderator: Mateo Mejia Saldarriaga, MD – Weill Cornell Medicine

  Panelist: Adriana Rossi, MD – Mount Sinai School of Medicine